Right Now
Fish Oil EPA and DHA Industry Analysis: the global Fish Oil EPA and DHA market size is projected to reach USD 2.02 billion by 2031
Fish Oil is a kind of oil extracted from fatty fish. It is rich in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and various N-3 Polyunsaturated Fatty Acids (N-3PUFA), which are essential unsaturated fatty acids for the human body. EPA can clean up blood vessel waste, soften blood vessels and improve immunity, and is known as the "Blood Vessel Scavenger"; DHA is often used for pregnant women and infants. By taking DHA, it can promote the normal growth and development of the brain, thus playing a so-called brain-boosting and intelligence-enhancing effect, commonly known as "Brain Gold".
Market Drivers:
Rising Burden of Chronic Diseases Fuels Preventive Nutrition: As cardiovascular diseases, diabetes, neurodegenerative disorders, and systemic inflammation become global public health challenges, demand for preventive and functional nutrition is rising. EPA is well-known for its anti-inflammatory and triglyceride-lowering effects, while DHA supports neural and retinal development. These health benefits position EPA and DHA as essential components of daily supplementation, increasingly recommended by healthcare professionals.
Growing Focus on Cognitive and Brain Health Accelerates DHA Demand: With aging populations and heightened awareness of childhood cognitive development, DHA is gaining traction as a key structural component of the brain and nervous system. DHA supplementation is now routine in prenatal supplements, infant formula, and cognitive support products for aging adults, making it a central growth driver in the omega-3 category.
Expanding Middle Class and Health-Conscious Consumers Boost Uptake: In emerging markets, especially in Asia-Pacific, the expanding middle class and rising health literacy are driving the shift from curative medicine to preventive self-care. Fish oil supplements are increasingly viewed as affordable and accessible wellness investments by families looking to maintain long-term health.
Functional Food Trend Broadens Application Scenarios: Consumers are moving beyond traditional capsules, seeking functional foods and beverages with embedded health benefits. EPA and DHA are now being fortified into dairy products, yogurts, breakfast cereals, infant foods, and energy drinks. This shift allows omega-3s to reach a wider audience through daily consumption habits, expanding both volumes and margins.
Pharmaceutical-Grade EPA Adoption Reinforces Clinical Value: Prescription EPA products like icosapent ethyl have demonstrated strong clinical benefits in reducing cardiovascular risk. As more regulatory bodies and health systems embrace these results, the pharmaceutical segment is emerging as a high-value growth pillar, pushing the omega-3 industry further into the healthcare domain.
Advancements in Purification Technology Improve Quality and Appeal: Historically, concerns over fishy taste, oxidation, and contamination hindered broader omega-3 adoption. Today, molecular distillation, supercritical CO₂ extraction, and re-esterification techniques have led to purer, better-tasting, and more bioavailable products, greatly enhancing consumer trust and satisfaction.
Market Challenges
Regulatory Complexity and Global Inconsistency: EPA and DHA products face fragmented regulations across regions. In some countries, they are treated as supplements, in others as pharmaceuticals, each with different compliance burdens. Moreover, emerging requirements for oxidation levels, heavy metals, and labelling transparency increase operational complexity and cost.
Consumer Scepticism and Misinformation: Despite growing health awareness, omega-3 supplements often face consumer hesitation due to concerns about heavy metal contamination, fishy aftertaste, or inconsistent efficacy. The presence of lower-quality products in the market also erodes trust.
Competition from Alternative Sources: Plant-based omega-3s (e.g., flaxseed, chia), krill oil, and algae-based DHA are gaining popularity, especially among vegetarians, pregnant women, and younger eco-conscious consumers. While not always direct substitutes for EPA/DHA, they pose a perception and positioning challenge.
According to the new market research report “Fish Oil EPA and DHA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the global Fish Oil EPA and DHA market size is projected to reach USD 2.02 billion by 2031, at a CAGR of 3.4% during the forecast period.
Figure00001. Global Fish Oil EPA and DHA Market Size (US$ Million), 2020-2031
Source: QYResearch, "Fish Oil EPA and DHA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”
Figure00002. Global Fish Oil EPA and DHA Top 20 Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)
Source: QYResearch, "Fish Oil EPA and DHA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”
According to QYResearch Top Players Research Center, the global key manufacturers of Fish Oil EPA and DHA include KD Pharma, Croda, BASF, Yuwang Pharma, GC Rieber VivoMega, Pelagia (EPAX), Golden Omega, TASA, KinOmega Biopharm, Omega Protein, etc. In 2024, the global top 10 players had a share approximately 64.0% in terms of revenue.
In terms of product type, currently Fish Oil DHA is the largest segment, hold a share of 76.8%.
In terms of product application, currently Dietary Supplements is the largest segment, hold a share of 52.2%.
About The Authors
Liu Wang- Lead Author |
Email: wangliu@qyresearch.com Tel: +86 15755356372 |
Ms. Wang has 7 years of industry research experience. She focuses on research related to the industry chain of automotive, consumer goods, software, and services, including auto parts, advanced automotive materials, various popular software, etc. Some research topics include Automotive Air Conditioning Electric Scroll Compressors, Lithium Battery Aluminum Plastic Film, Model-based Development (MBD), Predictive Maintenance Solutions, Webtoons, 3D models, Cloud Gaming Backend Service, Visual Content, DHA from Algae, etc. As an analyst with many years of experience in the consulting industry, she has a keen insight into the industry's market trends and developments and uses data analysis to discover potential market opportunities and threats, providing data support for corporate strategic decisions. |
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)
More Posts
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
